| 1 |
23543234 | (99m)Tc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study. | 2013 Jun |
2 |
| 2 |
19783150 | Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent. | 2010 Jan |
1 |
| 3 |
17538395 | MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy. | 2007 Jul |
1 |
| 4 |
16569203 | 99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response. | 2006 Spring |
1 |
| 5 |
15360048 | Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines. | 2004 |
2 |
| 6 |
12830325 | In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance. | 2003 Aug |
1 |
| 7 |
11466674 | Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients. | 2001 Jul 15 |
3 |
| 8 |
11598111 | MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potential. | 2001 Dec 28 |
3 |
| 9 |
10097135 | Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. | 1999 Mar 30 |
1 |
| 10 |
8623497 | Applications of 99mTc-sestamibi in oncology. | 1996 Jan-Feb |
2 |